<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Yunsheng Ma</title>
<copyright>Copyright (c) 2011  All rights reserved.</copyright>
<link>http://works.bepress.com/may</link>
<description>Recent documents in Yunsheng Ma</description>
<language>en-us</language>
<lastBuildDate>Sun, 13 Nov 2011 01:45:48 PST</lastBuildDate>
<ttl>3600</ttl>


	
		
	

	
		
	







<item>
<title>Association of Post-Traumatic Stress Disorder and Obesity in a Nationally Representative Sample</title>
<link>http://works.bepress.com/may/79</link>
<guid isPermaLink="true">http://works.bepress.com/may/79</guid>
<pubDate>Fri, 11 Nov 2011 10:59:21 PST</pubDate>
<description>
	<![CDATA[
	<p>Recent studies suggest a possible link between post-traumatic stress disorder (PTSD) and obesity risk, which would have implications for the development of obesity-related diseases in this population. The present study examined the association between PTSD and obesity and whether this association differed by sex in a representative sample of the US population. A secondary objective was to determine whether the association between PTSD and obesity was mediated by binge eating disorder (BED). Data were from the Collaborative Psychiatric Epidemiology Surveys (CPES), which comprises three nationally representative cross-sectional surveys that were conducted between 2001 and 2003. Logistic regression analyses weighted to represent the general US adult population were performed. In the total sample of 20,013 participants, rates of obesity were 24.1% for persons without a lifetime history of PTSD and 32.6% among persons with PTSD in the past year. Adjusting for socio-demographic characteristics, depression, substance and alcohol abuse/dependence, and psychotropic medication status, past year PTSD was associated with greater likelihood of obesity (odds ratio (OR) = 1.51; 95% confidence interval (CI) = 1.18, 1.95), with no differences by gender. BED did not statistically mediate the relationship between PTSD and obesity. The present study provides support for a link between PTSD and obesity. Findings further existing literature by indicating that the association is consistent across sexes and is not statistically mediated by BED.</p>

	]]>
</description>

<author>Sherry L. Pagoto et al.</author>


<category>Stress Disorders, Post-Traumatic</category>

<category>Obesity</category>

</item>






<item>
<title>Simple messages to improve dietary quality: A pilot investigation</title>
<link>http://works.bepress.com/may/78</link>
<guid isPermaLink="true">http://works.bepress.com/may/78</guid>
<pubDate>Fri, 11 Nov 2011 10:59:17 PST</pubDate>
<description>
	<![CDATA[
	<p>Public health recommendations for a healthy diet often involve complex messages, requiring in-depth knowledge for understanding and compliance.  The present study compared the feasibility and initial efficacy of two simple messages (a high fiber diet or a low saturated fat diet) to a combination message (high fiber and low saturated fat) on the potential to impact dietary quality and metabolic health.  Conclusions: A simple dietary message appears to improve overall dietary quality and aid in weight management.  Simple messages are a novel approach which could make a significant impact on the prevention and treatment of chronic disease as well as weight management.  Results support the need for a larger randomized controlled trial that is powered to examine the efficacy of a simplified dietary recommendation for dietary quality and metabolic health.  It would be worth exploring the impact of simple messages in a larger trial to determine their usefulness as simple public health messages as an alternative the current complex recommendations.</p>
<p>Citation:  Olendzki B, Ma Y, Schneider K, Merriam P, Culver A, Ockene I, Pagoto S. Simple messages to improve dietary quality: A pilot investigation.   American Dietetic Association Annual Meeting, October 2008, Chicago, Ill.  <ol> </ol></p>

	]]>
</description>

<author>Barbara C. Olendzki et al.</author>


<category>Food Habits</category>

<category>Diet</category>

<category>Health Behavior</category>

</item>






<item>
<title>Pilot Testing a Novel Treatment for Inflammatory Bowel Disease</title>
<link>http://works.bepress.com/may/77</link>
<guid isPermaLink="true">http://works.bepress.com/may/77</guid>
<pubDate>Tue, 01 Nov 2011 07:29:13 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>Background:</strong> Inflammatory Bowel Disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), are chronic non specific inflammatory conditions.  Standard IBD treatment typically employs a combination of anti-inflammatory and immune suppressive medications; however, the pharmacological approach is not by itself curative. The Anti-Inflammatory Diet for IBD (IBD-AID), which is derived and augmented from The Specific Carbohydrate Diet (SCD), is a nutritional regimen that restricts the intake of complex carbohydrates such as refined sugar, gluten-based grains, and certain starches from the diet.  These carbohydrates are thought to provide a substrate for pro-inflammatory bacteria.  The second component of the diet involves the ingestion of pre- and probiotics to help restore an anti inflammatory environment.</p>
<p><strong>Study Objective: </strong>To assess the efficacy and feasibility of the Anti –Inflammatory Diet (IBD-AID) intervention for the treatment of IBD.</p>
<p><strong>Intervention:</strong> Patients were recruited from the UMMHC gastroenterology clinic upon referral from their gastroenterologist.  They received individual instruction of the diet and its restrictions through 5 individual nutrition sessions over approximately a 6-10 month period. Support materials were provided. Cooking classes were also available to the patients.</p>
<p><strong>Conclusion:</strong> This case series indicates the potential for the IBD-AID to be used as an adjunctive or alternative therapy for the treatment of IBD. Notably, 9 out of 11 patients were able to be managed without anti-TNF therapy, and 100% of the patients had their symptoms reduced.  To make clear recommendations for its use in clinical practice, randomized trials are needed alongside strategies to improve acceptability and compliance with the IBD-AID.</p>

	]]>
</description>

<author>Barbara C. Olendzki et al.</author>


</item>






<item>
<title>Eating Patterns in a Free-Living Healthy U. S. Adult Population</title>
<link>http://works.bepress.com/may/76</link>
<guid isPermaLink="true">http://works.bepress.com/may/76</guid>
<pubDate>Fri, 28 Oct 2011 11:13:09 PDT</pubDate>
<description>
	<![CDATA[
	<p>The primary objective of this study was to describe eating patterns (<em>e.g</em>.,  breakfast, lunch, dinner, snacking, number of eating episodes, temporal  patterns of eating across the 24-hour day, and the frequency of eating  out) in a healthy U.S. population in order to provide a basis for future  studies on the association between eating patterns and disease.  Twenty-four hour dietary recalls were used to assess eating patterns,  and cross-sectional analyses were conducted. Ninety-six percent of  subjects usually consumed breakfast, 78% consumed lunch, 95% consumed  dinner, and 60% consumed snacks. On average, participants ate 3.92 times  daily (standard deviation(SD)=0.8). Caloric intake on weekend days was  significantly greater than on weekdays. There was a tendency of  participants to eat meals frequently outside of the home.</p>

	]]>
</description>

<author>Yunsheng Ma et al.</author>


<category>Feeding Behavior</category>

</item>






<item>
<title>Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder</title>
<link>http://works.bepress.com/may/75</link>
<guid isPermaLink="true">http://works.bepress.com/may/75</guid>
<pubDate>Tue, 20 Sep 2011 05:33:39 PDT</pubDate>
<description>
	<![CDATA[
	<p><strong>Background</strong></p>
<p>The comorbidity of type 2 diabetes mellitus (T2DM) and depression is associated with poor glycemic control. Exercise has been shown to improve mood and glycemic control, but individuals with comorbid T2DM  and depression are disproportionately sedentary compared to the general  population and report more difficulty with exercise. Behavioral  activation, an evidence-based depression psychotherapy, was designed to  help people with depression make gradual behavior changes, and may be  helpful to build exercise adherence in sedentary populations. This pilot  randomized clinical trial will test the feasibility of a group exercise  program enhanced with behavioral activation strategies among women with  comorbid T2DM and depression.</p>
<p><strong>Methods/design</strong></p>
<p>Sedentary women with inadequately controlled T2DM  and depression (N = 60) will be randomly assigned to one of two  conditions: exercise or usual care. Participants randomized to the  exercise condition will attend 38 behavioral activation-enhanced group  exercise classes over 24 weeks in addition to usual care. Participants  randomized to the usual care condition will receive depression treatment  referrals and print information on diabetes  management via diet and physical activity. Assessments will occur at  baseline and 3-, 6-, and 9-months following randomization. The goals of  this pilot study are to demonstrate feasibility and intervention  acceptability, estimate the resources and costs required to deliver the  intervention and to estimate the standard deviation of continuous  outcomes (e.g., depressive symptoms and glycosylated hemoglobin) in  preparation for a fully-powered randomized clinical trial.</p>
<p><strong>Discussion</strong></p>
<p>A  novel intervention that combines exercise and behavioral activation  strategies could potentially improve glycemic control and mood in women  with comorbid type 2 diabetes and depression.</p>
<p>Trial registration: NCT01024790.</p>

	]]>
</description>

<author>Kristin L. Schneider et al.</author>


<category>Diabetes Mellitus, Type 2</category>

<category>Depressive Disorder, Major</category>

<category>Exercise</category>

<category>Health Behavior</category>

</item>






<item>
<title>Elevated Depressive Symptoms, Antidepressant Use, and Diabetes in a Large Multiethnic National Sample of Postmenopausal Women</title>
<link>http://works.bepress.com/may/74</link>
<guid isPermaLink="true">http://works.bepress.com/may/74</guid>
<pubDate>Tue, 20 Sep 2011 05:33:35 PDT</pubDate>
<description>
	<![CDATA[
	<p><p id="x-x-p-2"><strong>OBJECTIVE</strong> To examine  elevated depressive symptoms and antidepressant use in relation to  diabetes incidence in the Women’s Health Initiative.    <p id="x-x-p-3"><strong>RESEARCH DESIGN AND METHODS</strong> A total of 161,808 postmenopausal women were followed for over an  average of 7.6 years. Hazard ratios (HRs) estimating the                         effects of elevated depressive symptoms and  antidepressant use on newly diagnosed incident diabetes were obtained  using Cox                         proportional hazards models adjusted for known  diabetes risk factors.    <p id="x-x-p-4"><strong>RESULTS</strong> Multivariable-adjusted HRs indicated an increased risk of incident  diabetes with elevated baseline depressive symptoms (HR                         1.14 [95% CI 1.08–1.21]) and antidepressant use  (1.20 [1.09–1.32]). These associations persisted in year 3 data, in  which                         respective adjusted HRs were 1.23 (1.09–1.39)  and 1.31 (1.14–1.50).    <p id="x-x-p-5"><strong>CONCLUSIONS</strong> Postmenopausal women with elevated depressive symptoms and who use  antidepressants have a greater risk of developing incident                         diabetes. In addition, longstanding elevated  depressive symptoms and recent antidepressant medication use increase  the risk                         of incident diabetes.</p>

	]]>
</description>

<author>Yunsheng Ma et al.</author>


<category>Postmenopause</category>

<category>Depression</category>

<category>Antidepressive Agents</category>

<category>Diabetes Mellitus</category>

<category>Women&apos;s Health</category>

</item>






<item>
<title>Association between Depression and C-Reactive Protein</title>
<link>http://works.bepress.com/may/73</link>
<guid isPermaLink="true">http://works.bepress.com/may/73</guid>
<pubDate>Tue, 23 Nov 2010 08:11:34 PST</pubDate>
<description>
	<![CDATA[
	<p>Objective: Depression has been associated with increased cardiovascular disease risk, and a depression–related elevation of high sensitivity C-reactive protein (hs-CRP) has been proposed as a possible mechanism. The objective of this study was to examine association between 27 depression and high sensitivity C-reactive protein (hs-CRP).</p>
<p>Methods: Subjects consisted of 508 healthy adults (mean age 48.5 years; 49% women, 88% white) residing in central Massachusetts. Data were collected at baseline and at quarterly intervals over a one-year period per individual. Multivariable linear mixed models were used to assess the association for the entire sample and by gender.</p>
<p>Results: The mean Beck Depression Inventory score was 5.8 (standard deviation (SD) 5.4; median 4.3), and average serum hs-CRP was 1.8 mg/L (SD 1.7; median 1.2). Results from the multivariable linear mixed models show that individuals with higher depression scores have higher levels of hs-CRP. Analyses by gender show persistence of an independent association among women, but not among men. Body mass index (BMI=weight(kg)/height(m)2) appears to be a partial mediator of this relationship.</p>
<p>Conclusion: Depression score was correlated to hs-CRP levels in women. Further studies are required to elucidate the biological mechanisms underlying these associations and their implications.</p>

	]]>
</description>

<author>Yunsheng Ma et al.</author>


<category>C-Reactive Protein</category>

<category>Depression</category>

<category>Sex Factors</category>

<category>Longitudinal Studies</category>

</item>






<item>
<title>Predictors of quality of life in Chinese patients with acute coronary syndrome</title>
<link>http://works.bepress.com/may/72</link>
<guid isPermaLink="true">http://works.bepress.com/may/72</guid>
<pubDate>Tue, 23 Nov 2010 08:11:32 PST</pubDate>
<description>
	<![CDATA[
	<p>Predictors of quality of life in Chinese patients with acute coronary syndrome remain unknown. Between January 2006 and March 2009, a prospective cohort study of 782 patients with acute coronary syndrome was carried out, with follow-up 7 months later. Depression and anxiety symptoms were measured using the Hospital Anxiety and Depression Scale. Quality of life was assessed using the 36-Item Short-Form Health Survey. To identify predictors of decreased quality of life, both the physical and mental component summary scores were analyzed using multiple and ordinal logistic regression. In our quality-of-life model, diabetes mellitus was an independent risk factor for a low mental component summary score. Anxiety symptoms and the baseline mental component summary score were significant independent predictors of a low mental component summary score. Acute myocardial infarction was found to be a risk factor for a low physical component summary score. Anxiety symptoms, baseline physical component summary score, and systolic blood pressure on admission were significant independent predictive factors. Among patients with acute coronary syndrome, those with acute myocardial infarction, diabetes, or a low baseline quality of life need more care and effective intervention to improve their quality of life.</p>

	]]>
</description>

<author>Wenlin Ma et al.</author>


<category>Acute Coronary Syndrome</category>

<category>Quality of Life</category>

</item>






<item>
<title>Sensitivity and specificity of the ankle–brachial index to diagnose peripheral artery disease: a structured review</title>
<link>http://works.bepress.com/may/71</link>
<guid isPermaLink="true">http://works.bepress.com/may/71</guid>
<pubDate>Tue, 23 Nov 2010 08:11:30 PST</pubDate>
<description>
	<![CDATA[
	<p>The ankle—brachial index (ABI) is a simple, inexpensive diagnostic test for peripheral artery disease (PAD). However, it has shown variable accuracy for identification of significant stenosis. The authors performed a structured review of the sensitivity and specificity of ABI ≤ 0.90 for the diagnosis of PAD. MEDLINE, EMBASE, Cochrane databases, Science Citation Index database, and Biological Abstracts database were searched for studies of the sensitivity and specificity of using ABI ≤ 0.90 for the diagnosis of PAD. Eight studies comprising 2043 patients (or limbs) met the inclusion criteria. The result indicated that, although strict inclusion criteria on studies were formulated, different reference standards were found in these studies, and methods of ABI determination and characteristics of populations varied greatly. A high level of specificity (83.3—99.0%) and accuracy (72.1—89.2%) was reported for an ABI ≤ 0.90 in detecting ≥ 50% stenosis, but there were different levels of sensitivity (15—79%). Sensitivity was low, especially in elderly individuals and patients with diabetes. In conclusion, the test of ABI ≤ 0.90 can be a simple and useful tool to identify PAD with serious stenosis, and may be substituted for other non-invasive tests in clinical practice.</p>

	]]>
</description>

<author>Dachun Xu et al.</author>


<category>Ankle Brachial Index</category>

<category>Peripheral Vascular Diseases</category>

</item>






<item>
<title>Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease</title>
<link>http://works.bepress.com/may/70</link>
<guid isPermaLink="true">http://works.bepress.com/may/70</guid>
<pubDate>Tue, 23 Nov 2010 08:11:27 PST</pubDate>
<description>
	<![CDATA[
	<p>A randomized trial of a pharmacist-delivered intervention (PI) versus usual care (UC) was conducted; 689 subjects with known coronary heart disease were recruited from cardiac catheterization laboratories. Participants in the PI condition received 5 pharmacist-delivered telephone counseling calls post-hospital discharge. At one year, 65% in the PI condition and 60% in the UC condition achieved an LDL-C level <100 mg>/dL (P=.29); mean statin adherence was 0.88 in the PI, and 0.90 in the UC (P=.51). The highest percentage of those who reached the LDL-C goal were participants who used statins as opposed to those who did not use statins (67% versus 58%, P=.05). However, only 53% and 56% of the patients in the UC and PI conditions, respectively, were using statins. We conclude that a pharmacist-delivered intervention aimed only at improving patient adherence is unlikely to positively affect outcomes. Efforts must be oriented towards influencing physicians to increase statin prescription rates.</p>

	]]>
</description>

<author>Yunsheng Ma et al.</author>


<category>Coronary Disease</category>

<category>Intervention Studies</category>

<category>Pharmacists</category>

<category>Patient Compliance</category>

<category>Medication Adherence</category>

<category>Hydroxymethylglutaryl-CoA Reductase Inhibitors</category>

</item>






<item>
<title>What are patients actually eating: the dietary practices of cardiovascular disease patients</title>
<link>http://works.bepress.com/may/69</link>
<guid isPermaLink="true">http://works.bepress.com/may/69</guid>
<pubDate>Tue, 23 Nov 2010 08:11:23 PST</pubDate>
<description>
	<![CDATA[
	<p>PURPOSE OF REVIEW: To examine dietary quality for patients after a coronary heart disease (CHD) event using a selective review.</p>
<p>RECENT FINDINGS: Poor dietary quality is a risk for patients before and after CHD events. Although cardiac rehabilitation programs often contain a nutrition education component and are advised for many patients, few patients attend cardiac rehabilitation. The American population experiences many difficulties with adherence to a higher-quality diet. A diet high in dietary quality is important in reducing risk of recurrent disease, yet few patients who have faced life-threatening cardiac events are adherent to such dietary recommendations.</p>
<p>SUMMARY: A review of the literature indicates the need for postevent dietary evaluation and effective nutrition counseling with ongoing follow-up. In addition, we need to demonstrate the effectiveness of such approaches.</p>

	]]>
</description>

<author>Yunsheng Ma et al.</author>


<category>Coronary Disease</category>

<category> *Diet</category>

<category>Humans</category>

<category>Risk Factors</category>

</item>






<item>
<title>The sunless study: a beach randomized trial of a skin cancer prevention intervention promoting sunless tanning</title>
<link>http://works.bepress.com/may/68</link>
<guid isPermaLink="true">http://works.bepress.com/may/68</guid>
<pubDate>Tue, 28 Sep 2010 05:46:20 PDT</pubDate>
<description>
	<![CDATA[
	<p>Objective: To examine the impact of a skin cancer prevention intervention that promoted sunless tanning as a substitute for sunbathing.</p>
<p>Design:  Randomized controlled trial.</p>
<p>Setting:  Public beaches in Massachusetts.</p>
<p>Participants:  Women (N = 250) were recruited to participate in the study during their visit to a public beach.</p>
<p>Intervention:  The intervention included motivational messages to use sunless tanning as an alternative to UV tanning, instructions for proper use of sunless tanning products, attractive images of women with sunless tans, a free trial of a sunless tanning product, skin cancer education, and UV imaging. The control participants completed surveys.</p>
<p>Main Outcome Measures:  The primary outcome was sunbathing 2 months and 1 year after the intervention. Secondary outcomes included sunburns, sun protection use, and sunless tanning.</p>
<p>Results:  At 2 months, intervention participants reduced their sunbathing significantly more than did controls and reported significantly fewer sunburns and greater use of protective clothing. At 1 year, intervention participants reported significant decreases in sunbathing and increases in sunless tanning relative to control participants but no differences in the other outcomes.</p>
<p>Conclusion:  This intervention, which promoted sunless tanning as an alternative to UV tanning, had a short-term effect on sunbathing, sunburns, and use of protective clothing and a longer-term effect on sunbathing and sunless tanning.</p>
<p>Trial Registration:  clinicaltrials.gov Identifier: NCT00403377</p>

	]]>
</description>

<author>Sherry L. Pagoto et al.</author>


<category>Sunbathing</category>

<category>Skin Neoplasms</category>

<category>Suntan</category>

<category>Health Promotion</category>

<category>Cosmetics</category>

<category>Attitude to Health</category>

<category>Women</category>

<category>Intervention Studies</category>

</item>






<item>
<title>Association Between Obesity and Asthma among Adults: A Hospital Based Case-Control Study</title>
<link>http://works.bepress.com/may/67</link>
<guid isPermaLink="true">http://works.bepress.com/may/67</guid>
<pubDate>Mon, 19 Jul 2010 10:51:04 PDT</pubDate>
<description>
	<![CDATA[
	<p>The aim is to study the association between obesity and asthma among adults by gender. The prevalences of both asthma and obesity have increased substantially in recent decades, leading to speculation that obese individuals might be at risk of asthma. However, the evidence of a relationship between obesity and asthma is not fully conclusive among adults. Hence we investigate the association between obesity and asthma among men and women using both measured weight and height and self-reported weight and height while controlling for the effects of the demographic and environmental factors. This case-control study involves a total of 159 adults; 53 cases and 106 controls enrolled in the month of July 2009 at PSG Hospitals. Body Mass Index (BMI) was calculated based on measured weight and height. The Odds Ratio (OR) with 95% confidence interval for obese individuals was estimated using logistic regression analysis with SPSS 11.5 for windows software (SPSS Inc., Chicago, Illinois). Multivariate logistic regression model was used to adjust all risk estimates for covariates. Obese women were found to have 9.14 times the risk of asthma than non obese women (95% confidence interval (CI):1.38, 35.68) after adjusting for covariates, such as age, education, environmental tobacco smoke and pet keeping. No significant association was observed among men although the direction of association is positive; adjusted odds ratio was 1.06 (95% CI: 0.12, 9.70). No significant association was observed between self-reported prevalence of obesity and asthma; among women, adjusted odds ratio = 4.33 (95% CI: 0.69, 27.37); and among men, adjusted odds ratio = 0.89 (95% CI: 0.11, 7.12). The study indicates a strong positive association between obesity and asthma among adult Indian women. The causal links between obesity and asthma by gender need to be further examined using prospective cohort studies.</p>

	]]>
</description>

<author>A. C. Mathew et al.</author>


<category>Obesity</category>

<category>Asthma</category>

<category>India</category>

<category>Adult</category>

</item>






<item>
<title>Peripheral arterial disease, chronic kidney disease, and mortality: The Chinese Ankle Brachial Index Cohort Study</title>
<link>http://works.bepress.com/may/66</link>
<guid isPermaLink="true">http://works.bepress.com/may/66</guid>
<pubDate>Mon, 19 Jul 2010 10:51:03 PDT</pubDate>
<description>
	<![CDATA[
	<p>The purpose of this study was to investigate the association between chronic kidney disease (CKD) and peripheral arterial disease (PAD) and examine the combined effect of CKD and PAD on all-cause and cardiovascular disease (CVD) mortality. The Chinese Ankle Brachial Index Cohort consisted of 3732 adults aged 35 years or older enrolled in 2004 and followed-up in 2007. Complete baseline data were compiled on 3610 people which were examined in the final analysis. Mortality surveillance was completed from December 2007 to February 2008. Survival analysis was used to compare the survival rate in different CKD/PAD groups. The relative risks (RR) of death from all-cause and CVD were compared using a Cox regression model. It was found that the prevalence of PAD in patients with and without CKD was 41.9% and 22.3%, respectively (p < 0.001). The survival rate for the CKD and PAD group was significantly lower than that for any single disease, for both all-cause and CVD mortality (log-rank: p < 0.001). In conclusion, CKD is a risk factor for PAD. The combined CKD and PAD patients had the highest risk for all-cause and CVD mortality. Early recognition of risk can be made by taking an ankle-brachial index measurement of PAD; a corresponding laboratory assessment should be used as a measurement of renal function for PAD patients.</p>

	]]>
</description>

<author>Yingyi Luo et al.</author>


<category>Kidney Diseases</category>

<category>Peripheral Vascular Diseases</category>

<category>Cardiovascular Diseases</category>

<category>Mortality</category>

</item>






<item>
<title>Sequence and seasonal effects of salivary cortisol</title>
<link>http://works.bepress.com/may/65</link>
<guid isPermaLink="true">http://works.bepress.com/may/65</guid>
<pubDate>Mon, 15 Mar 2010 08:35:03 PDT</pubDate>
<description>
	<![CDATA[
	<p>Assessments of cortisol levels in saliva have been widely used by both researchers and clinicians as an index of adrenal functioning. Quarterly measurements of morning and evening cortisol levels were determined in a longitudinal study of 147 participants (72 women and 75 men) followed for 1 year each. The analysis of salivary cortisol revealed no significant gender or age differences in the sample. There was a sequence effect in quarterly cortisol values with a progressive decrease in serial measurements, especially notable in the morning values; as well as a seasonal variation in cortisol levels with significantly higher levels found in winter and fall, compared with spring and summer. The findings in this study suggest that repeated saliva sampling and seasonal variation in cortisol levels may independently affect adrenal response and, therefore, need to be accounted for in longitudinal studies.</p>

	]]>
</description>

<author>Jean A. King et al.</author>


<category>Adult</category>

<category>Aged</category>

<category>Arousal</category>

<category>Cholesterol</category>

<category>Circadian Rhythm</category>

<category>Female</category>

<category>Humans</category>

<category>Hydrocortisone</category>

<category>Hypothalamo-Hypophyseal System</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Pituitary-Adrenal System</category>

<category>Reference Values</category>

<category>Saliva</category>

<category>  *Seasons</category>

</item>






<item>
<title>Association between dietary fiber and markers of systemic inflammation in the Women&apos;s Health Initiative Observational Study</title>
<link>http://works.bepress.com/may/64</link>
<guid isPermaLink="true">http://works.bepress.com/may/64</guid>
<pubDate>Mon, 15 Mar 2010 08:35:02 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: Systemic inflammation may play an important role in the development of atherosclerosis, type 2 diabetes, and some cancers. Few studies have comprehensively assessed the direct relations between dietary fiber and inflammatory cytokines, especially in minority populations. Using baseline data from 1958 postmenopausal women enrolled in the Women's Health Initiative Observational Study, we examined cross-sectional associations between dietary fiber intake and markers of systemic inflammation (including serum high-sensitivity C-reactive protein [hs-CRP], interleukin-6 [IL-6], and tumor necrosis factor-alpha receptor-2 [TNF-alpha-R2]) in addition to differences in these associations by ethnicity. METHODS: Multiple linear regression models were used to assess the relation between fiber intake and makers of systemic inflammation. RESULTS: After adjustment for covariates, intakes of dietary fiber were inversely associated with IL-6 (P values for trend were 0.01 for total fiber, 0.004 for soluble fiber, and 0.001 for insoluble fiber) and TNF-alpha-R2 (P values for trend were 0.002 for total, 0.02 for soluble, and <0.001 for insoluble fibers). Although the samples were small in minority Americans, results were generally consistent with those found among European Americans. We did not observe any significant association between intake of dietary fiber and hs-CRP. CONCLUSION: These findings lend support to the hypothesis that a high-fiber diet is associated with lower plasma levels of IL-6 and TNF-alpha-R2. Contrary to previous reports, however, there was no association between fiber and hs-CRP among postmenopausal women. Future studies on the influence of diet on inflammation should include IL-6 and TNF-alpha-R2 and enroll participants from ethnic minorities.</p>

	]]>
</description>

<author>Yunsheng Ma et al.</author>


<category>Aged</category>

<category>Biological Markers</category>

<category>C-Reactive Protein</category>

<category>Dietary Fiber</category>

<category>Ethnic Groups</category>

<category>Female</category>

<category>Humans</category>

<category>Inflammation</category>

<category>Interleukin-6</category>

<category>Linear Models</category>

<category>Middle Aged</category>

<category>Postmenopause</category>

<category>Receptors, Tumor Necrosis Factor, Type II</category>

<category>United States</category>

</item>






<item>
<title>Translating the diabetes prevention program into a hospital-based weight loss program</title>
<link>http://works.bepress.com/may/63</link>
<guid isPermaLink="true">http://works.bepress.com/may/63</guid>
<pubDate>Mon, 15 Mar 2010 08:35:02 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: Intensive lifestyle interventions have established efficacy, but translation to real-world settings has not been well demonstrated. Using the diffusion of innovations model, we describe the adoption of the Diabetes Prevention Program (DPP) Lifestyle Intervention into a hospital-based program and report feasibility, acceptability, and outcomes.</p>
<p>DESIGN: Patients (N = 118; 72% female, mean age = 48.8, mean baseline body mass index = 43.3) were enrolled into 16 weeks of DPP.</p>
<p>MAIN OUTCOME MEASURE: Weight loss (kg) was measured at baseline and after treatment.</p>
<p>RESULTS: Mean weight loss after 16 weeks was 5.57 kg (SD = 4.6) or 4.6% of baseline weight, and 30% met the 7% weight loss goal. Outcomes are compared with those reported in the DPP trial. Most participants (90.4%) were satisfied with the service; however, only 56% were satisfied with their weight loss.</p>
<p>CONCLUSION: The DPP was successfully translated into a real-world clinic with some protocol modifications. Weight loss was modest among heavier patients with more comorbidities than the original DPP sample. Diffusion of innovations theory provides a useful framework for adopting evidence-based programs in the clinical setting.</p>

	]]>
</description>

<author>Sherry L. Pagoto et al.</author>


<category>Adult</category>

<category>Diabetes Mellitus</category>

<category>Diffusion of Innovation</category>

<category>Female</category>

<category>Health Promotion</category>

<category> *Hospitals</category>

<category>Humans</category>

<category>Male</category>

<category>Massachusetts</category>

<category>Middle Aged</category>

<category> *Risk Reduction Behavior</category>

<category> *Weight Loss</category>

</item>






<item>
<title>Design and methods for a cluster randomized trial of the Sunless Study: a skin cancer prevention intervention promoting sunless tanning among beach visitors</title>
<link>http://works.bepress.com/may/62</link>
<guid isPermaLink="true">http://works.bepress.com/may/62</guid>
<pubDate>Mon, 15 Mar 2010 08:35:01 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Skin cancer is the most prevalent yet most preventable cancer in the US. While protecting oneself from ultraviolet radiation (UVR) can largely reduce risk, rates of unprotected sun exposure remain high. Because the desire to be tan often outweighs health concerns among sunbathers, very few interventions have been successful at reducing sunbathing behavior. Sunless tanning (self-tanners and spray tans), a method of achieving the suntanned look without UVR exposure, might be an effective supplement to prevention interventions.</p>
<p>METHODS AND DESIGN: This cluster randomized trial will examine whether a beach-based intervention that promotes sunless tanning as a substitute for sunbathing and includes sun damage imaging and sun safety recommendations is superior to a questionnaire only control group in reducing sunbathing frequency. Female beach visitors (N = 250) will be recruited from 2 public beaches in eastern Massachusetts. Beach site will be the unit of randomization. Follow-up assessment will occur at the end of the summer (1-month following intervention) and 1 year later. The primary outcome is average sunbathing time per week. The study was designed to provide 90% power for detecting a difference of .70 hours between conditions (standard deviation of 2.0) at 1-year with an intra-cluster correlation coefficient of 0.01 and assuming a 25% rate of loss to follow-up. Secondary outcomes include frequency of sunburns, use of sunless tanning products, and sun protection behavior.</p>
<p>DISCUSSION: Interventions might be improved by promoting behavioral substitutes for sun exposure, such as sunless tanners, that create a tanned look without exposure to UVR.</p>
<p>TRIAL REGISTRATION: NCT00403377.</p>

	]]>
</description>

<author>Sherry L. Pagoto et al.</author>


<category>Adolescent</category>

<category>Adult</category>

<category>Aged</category>

<category> *Attitude to Health</category>

<category>Bathing Beaches</category>

<category>Cluster Analysis</category>

<category> *Cosmetics</category>

<category>Female</category>

<category>Health Behavior</category>

<category>Health Promotion</category>

<category>Humans</category>

<category>Intervention Studies</category>

<category>Longitudinal Studies</category>

<category>Massachusetts</category>

<category>Middle Aged</category>

<category>Primary Prevention</category>

<category>Reference Values</category>

<category>Sensitivity and Specificity</category>

<category>Skin Neoplasms</category>

<category> *Sunbathing</category>

<category>Sunlight</category>

<category> *Suntan</category>

<category>Young Adult</category>

</item>






<item>
<title>Initial investigation of behavioral activation therapy for co-morbid major depressive disorder and obesity.</title>
<link>http://works.bepress.com/may/61</link>
<guid isPermaLink="true">http://works.bepress.com/may/61</guid>
<pubDate>Mon, 15 Mar 2010 08:35:00 PDT</pubDate>
<description>
	<![CDATA[
	<p>More than one-third of treatment-seeking obese patients are clinically depressed. No evidence-based treatments exist for individuals with comorbid depression and obesity. Behavioral activation (BA), an effective treatment for depression, might also facilitate weight loss. The objective of this study is to evaluate the feasibility and efficacy of BA plus nutrition counseling for weight loss among individuals with comorbid major depressive disorder (MDD) and obesity. The BA intervention targeted both weight reduction and depression in 14 obese patients (79% female; 86% Caucasian) who met criteria for MDD. At baseline, mean Beck Depression Inventory (BDI-II) score was 26.71, and mean Hamilton Depression Rating Scale (HDRS) score was 16.00. Significant reductions at 12-weeks in both BDI-II and HDRS were observed with 10 participants reaching full remission at post treatment. Reductions in body weight, daily caloric intake, and physical activity were observed. BA with nutrition counseling appears to have potential as a weight loss treatment in the context of depression. Results support the need for a randomized controlled trial to evaluate the efficacy of BA for both weight loss and depression.</p>

	]]>
</description>

<author>Sherry L. Pagoto et al.</author>


<category>Behavior Therapy</category>

<category>Comorbidity</category>

<category>Depressive Disorder, Major</category>

<category>Obesity</category>

</item>






<item>
<title>Association between dietary glycemic index, glycemic load, and high-sensitivity C-reactive protein</title>
<link>http://works.bepress.com/may/60</link>
<guid isPermaLink="true">http://works.bepress.com/may/60</guid>
<pubDate>Mon, 15 Mar 2010 08:34:59 PDT</pubDate>
<description>
	<![CDATA[
	<p>OBJECTIVE: This study examined the relation between quality of dietary carbohydrate intake, as measured by glycemic index (GI) and glycemic load (GL), and serum high-sensitivity C-reactive protein (hs-CRP) levels. METHODS: During a 1-y observational study, data were collected at baseline and at each quarter thereafter. GI and GL were calculated from multiple 24-h dietary recalls (24HRs), 3 randomly selected 24HRs at every quarter, with up to 15 24HRs per participant. The hs-CRP was measured in blood samples collected at baseline and each of the four quarterly measurement points. Multivariable linear mixed models were used to examine the cross-sectional and longitudinal associations of GI, GL, and hs-CRP. RESULTS: Among 582 adult men and women with at least two measurements of diet and hs-CRP, average daily GI score (white bread = 100) was 85 and average GL was 198, and average hs-CRP was 1.84 mg/L. Overall, there was no association between GI or GL and hs-CRP. Subgroup analyses revealed an inverse association between GL and hs-CRP among obese individuals (body mass index > or =30 kg/m(2)). CONCLUSION: Quality of dietary carbohydrates does not appear to be associated with serum hs-CRP levels. Among obese individuals, higher dietary GL appears to be related to lower hs-CRP levels. Due to the limited number of studies on this topic and their conflicting results, further investigation is warranted.</p>

	]]>
</description>

<author>Jennifer A. Griffith et al.</author>


<category>Adult</category>

<category>Aged</category>

<category>Biological Markers</category>

<category> *Body Mass Index</category>

<category>C-Reactive Protein</category>

<category>Cross-Sectional Studies</category>

<category>Dietary Carbohydrates</category>

<category>Female</category>

<category> *Glycemic Index</category>

<category>Humans</category>

<category>Linear Models</category>

<category>Longitudinal Studies</category>

<category>Male</category>

<category>Mental Recall</category>

<category>Middle Aged</category>

<category>Obesity</category>

<category>Prospective Studies</category>

</item>





</channel>
</rss>

